
FEATURED ARTICLES
-
Dr. Bobby Gaspar On Manufacturing, Commercialization Challenges
Orchard Therapeutics CEO Dr. Bobby Gaspar, M.D., Ph.D. is one of only a handful of gene therapy leaders to see the light of market-approved therapy. Here, he offers advice for those seeing manufacturing, regulatory, and reimbursement challenges for the first time.
- Hamilton Robotics Launches Highly Flexible PCR Setup Workstation
- BioReliance Acquires Rights To Big Blue Colonies And Cell Lines From Agilent
- Dako Receives FDA Approval For Fast, Accurate, Nontoxic FISH Assay For Cancer Diagnostics
- Pittcon 2013 Conference Tackles Life Sciences Challenges, Novel Research
This website uses cookies to ensure you get the best experience on our website. Learn more